Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047204
Filing Date
2024-11-12
Accepted
2024-11-12 16:30:57
Documents
108
Period of Report
2024-09-28

Document Format Files

Seq Description Document Type Size
1 10-Q alts-20240928.htm   iXBRL 10-Q 1637408
2 EX-3.21 ex321_alt5certificateofdes.htm EX-3.21 92892
3 EX-10.117 ex10117_formofassetpurchas.htm EX-10.117 156817
4 EX-31.1 alt5-20240928xexx311.htm EX-31.1 9609
5 EX-31.2 alt5-20240928xexx312.htm EX-31.2 9652
6 EX-32.1 alt5-20240928xexx321.htm EX-32.1 3685
7 EX-32.2 alt5-20240928xexx322.htm EX-32.2 3668
  Complete submission text file 0001628280-24-047204.txt   10435370

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alts-20240928.xsd EX-101.SCH 86308
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alts-20240928_cal.xml EX-101.CAL 83554
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alts-20240928_def.xml EX-101.DEF 470694
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alts-20240928_lab.xml EX-101.LAB 810415
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alts-20240928_pre.xml EX-101.PRE 667144
110 EXTRACTED XBRL INSTANCE DOCUMENT alts-20240928_htm.xml XML 1442302
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19621 | Film No.: 241448943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)